Terrana's innovative technology platform uses RNA-based plant health solutions to enable resilient agriculture for a world.
Terrana Biosciences has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in July 2025.
Terrana Biosciences's investors include Flagship Pioneering.
Terrana Biosciences is headquartered in Cambridge, United States.
Terrana's innovative technology platform uses RNA-based plant health solutions to enable resilient agriculture for a world.
Terrana Biosciences is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Terrana Biosciences — Funding & Investors." VCBacked, July 1, 2025, https://www.vcbacked.co/company/terrana-biosciences. Accessed September 15, 2026.
VCBacked. (2025). Terrana Biosciences — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/terrana-biosciences
{{cite web |title=Terrana Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/terrana-biosciences |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated